The global genomics market size is expected to reach USD 27.61 billion by 2025

Monday, October 7, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Oct. 7, 2019 /PRNewswire/ -- Genomics Market Size, Share & Trends Analysis Report By Application And Technology (Pathway Analysis, Functional Genomics), By Deliverables (Instruments, Consumables, Services), By End Use, And Segment Forecasts, 2019 - 2025

Download the full report:

The global genomics market size is expected to reach USD 27.61 billion by 2025. It is anticipated to

expand at a CAGR of 8.6% during the forecast period. The past decades have witnessed significant changes in disease management processes due to simultaneous advancements in genomics and personalized medicine. There has been a gradual growth in the usage of genomic studies in clinical practices, which is reflected by the growing trend of targeted therapies. Results from genomic studies enable a better understanding of diseases and the underlying mechanisms for researchers, physicians, and consumers.This facilitates evidence-based decision-making, and hence, helps improve personalized treatment regime. In addition, technological advancements in data analysis tools have motivated healthcare community to create precision-based therapies from surplus, available DNA data. Ability of the medical community to make use of the available genomic information in personalized medicine is anticipated to significantly impact the genomics market.Furthermore, plummeting cost of sequencing has enabled the whole genome sequencing at very less price. Scientists are combining the sequencing generated data with diagnostics which has proven its effectiveness in enhancing personalized treatment landscape. The companies are involved in strategic alliances with global as well as local entities to boost their revenue generation and enhance their market share. For instance, in March 2017, Foundation Medicine collaborated with Bristol-Myers Squibb Company, as a result of which Bristol-Myers Squibb could deploy Foundation Medicine's molecular information solutions and comprehensive genomic profiling for identification of predictive biomarkers, such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB), to accelerate its immunotherapy clinical trials. NGS-based services held a major market share in the services segment due to its rapid adoption of whole genome sequencing and application of sequence databases for disease screening and prognosis.The demand would remain strong with the expansion of the customer base from limited to academic and research centers to CROs, biotech and pharma players. As patients are focusing on their health, Direct-To-Consumer (DTC) laboratory testing is increasingly being employed. DTC genetic tests enable consumers to access information about their genetics without necessarily including healthcare professionals in the process. Further key findings from the report suggest: • High demand in terms of volume coupled with the high cost of specific reagents contribute to substantial revenue share. Companies are embracing the trend of offering varied reagents that simplify workflow process • Use of predictive biomarkers for diagnosis and monitoring take cancer eradication a step further. Moreover, organizations and programs such as the National Biomarker Development Alliance (NBDA) are actively participating in development of novel biomarkers for cancer diagnosis • Growing interest of pharmaceutical and biotechnology companies in genomics is expected to drive growth of the genomics market in the forthcoming years • Asia Pacific is anticipated to display the maximum potential and an become an emerging market for genomics. It is anticipated to register the fastest CAGR of 10.4% over the forecast period • Major players include BGI; Agilent Technologies; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc; Foundation Medicine, Inc, 23andMe, Inc, Danaher, Illumina, Inc; Pacific Biosciences; Oxford Nanopore Technologies.; F. Hoffmann-La Roche Ltd., and Myriad Genetics, Inc.Download the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Email: Tel: +1 (718) 213 4904 Website:

Cision View original content:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z



Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store